14th February 2024

A group of researchers are validating a new blood test for clinical use to predict patients who are developing early ovarian cancer.

A group of researchers are validating a new blood test for clinical use to predict patients who are developing early ovarian cancer. The study includes 1000 patients, 400 patients with known ovarian cancer and 600 control subjects. 200 patients with ovarian cancer had a positive blood test, while 550 control patients tested negative. 

What is the specificity of the test?